{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T13:38:51Z","timestamp":1770817131738,"version":"3.50.1"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":1093,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T00:00:00Z","timestamp":1668470400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Clinical trials comparing LVADs vs. conservative therapy were performed before the availability of novel medications or used suboptimal medical therapy. This study aimed to report that long-term stabilization of patients entering a left ventricular assist device (LVAD) programme is possible with the use of aggressive conservative therapy. This is important because the excellent clinical stabilization provided by LVADs comes at the expense of significant complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>This study was a single-centre prospective evaluation of consecutive patients with advanced heart failure (HF) fulfilling criteria for LVAD implantation based on clinical and echocardiographic characteristics, cardiopulmonary exercise test, and right heart catheterization results. Their initial therapy included inotropes, thiamine, beta-blockers, digoxin, spironolactone, hydralazine, and nitrates followed by the introduction of novel HF therapies. Coronary revascularization and cardiac resynchronization therapy were performed when indicated, and all patients were closely followed at our outpatient clinic. During the study period, 28 patients were considered suitable for LVAD implantation (mean age 63 \u00b1 10.8 years, 92% men, 78% ischaemic, median HF duration 4 years). Clinical stabilization was achieved and maintained in 21 patients (median follow-up 20 months, range 9\u201338 months). Compared with baseline evaluation, cardiac index increased from 2.05 (1.73\u20132.28) to 2.88 (2.63\u20133.55) L\/min\/m2, left ventricular end-diastolic diameter decreased from 65.5 (62.4\u201366) to 58.3 (53.8\u201362.5) mm, and maximal oxygen consumption increased from 10.1 (9.2\u201311.3) to 16.1 (15.3\u201319) mL\/kg\/min. Three patients died and only four ultimately required LVAD implantation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Notwithstanding the small size of our cohort, our results suggest that LVAD implantation could be safely deferred in the majority of LVAD candidates.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.14223","type":"journal-article","created":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T02:42:01Z","timestamp":1668566521000},"page":"601-615","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Successful Conservative Management of Left Ventricular Assist Device Candidates"],"prefix":"10.1093","volume":"10","author":[{"given":"Ofer","family":"Havakuk","sequence":"first","affiliation":[{"name":"Division of Cardiology, Tel Aviv Sourasky Medical Center , 6 Weissman Street, Tel Aviv, 64239 ,","place":["Israel"]},{"name":"Sackler School of Medicine, Tel Aviv University , Tel Aviv ,","place":["Israel"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aviram","family":"Hochstadt","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Tel Aviv Sourasky Medical Center , 6 Weissman Street, Tel Aviv, 64239 ,","place":["Israel"]},{"name":"Sackler School of Medicine, Tel Aviv University , Tel Aviv ,","place":["Israel"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sapir","family":"Sadon","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Tel Aviv Sourasky Medical Center , 6 Weissman Street, Tel Aviv, 64239 ,","place":["Israel"]},{"name":"Sackler School of Medicine, Tel Aviv University , Tel Aviv ,","place":["Israel"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Laurel Perl","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Tel Aviv Sourasky Medical Center , 6 Weissman Street, Tel Aviv, 64239 ,","place":["Israel"]},{"name":"Sackler School of Medicine, Tel Aviv University , Tel Aviv ,","place":["Israel"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben","family":"Sadeh","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Tel Aviv Sourasky Medical Center , 6 Weissman Street, Tel Aviv, 64239 ,","place":["Israel"]},{"name":"Sackler School of Medicine, Tel Aviv University , Tel Aviv ,","place":["Israel"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Assi","family":"Milwidsky","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Tel Aviv Sourasky Medical Center , 6 Weissman Street, Tel Aviv, 64239 ,","place":["Israel"]},{"name":"Sackler School of Medicine, Tel Aviv University , Tel Aviv ,","place":["Israel"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orly","family":"Ran Sapir","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Tel Aviv Sourasky Medical Center , 6 Weissman Street, Tel Aviv, 64239 ,","place":["Israel"]},{"name":"Sackler School of Medicine, Tel Aviv University , Tel Aviv ,","place":["Israel"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoav","family":"Granot","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Tel Aviv Sourasky Medical Center , 6 Weissman Street, Tel Aviv, 64239 ,","place":["Israel"]},{"name":"Sackler School of Medicine, Tel Aviv University , Tel Aviv ,","place":["Israel"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lior","family":"Lupu","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Tel Aviv Sourasky Medical Center , 6 Weissman Street, Tel Aviv, 64239 ,","place":["Israel"]},{"name":"Sackler School of Medicine, Tel Aviv University , Tel Aviv ,","place":["Israel"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erez","family":"Levi","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Tel Aviv Sourasky Medical Center , 6 Weissman Street, Tel Aviv, 64239 ,","place":["Israel"]},{"name":"Sackler School of Medicine, Tel Aviv University , Tel Aviv ,","place":["Israel"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariel","family":"Farkash","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Tel Aviv Sourasky Medical Center , 6 Weissman Street, Tel Aviv, 64239 ,","place":["Israel"]},{"name":"Sackler School of Medicine, Tel Aviv University , Tel Aviv ,","place":["Israel"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanai","family":"Ben Gal","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Tel Aviv Sourasky Medical Center , 6 Weissman Street, Tel Aviv, 64239 ,","place":["Israel"]},{"name":"Sackler School of Medicine, Tel Aviv University , Tel Aviv ,","place":["Israel"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shmuel","family":"Banai","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Tel Aviv Sourasky Medical Center , 6 Weissman Street, Tel Aviv, 64239 ,","place":["Israel"]},{"name":"Sackler School of Medicine, Tel Aviv University , Tel Aviv ,","place":["Israel"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Topilsky","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Tel Aviv Sourasky Medical Center , 6 Weissman Street, Tel Aviv, 64239 ,","place":["Israel"]},{"name":"Sackler School of Medicine, Tel Aviv University , Tel Aviv ,","place":["Israel"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,11,15]]},"reference":[{"key":"2026012114124493000_ehf214223-bib-0001","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jtcvs.2012.05.044","article-title":"Long-term mechanical circulatory support (destination therapy): on track to compete with heart transplantation?","volume":"144","author":"Kirklin","year":"2012","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2026012114124493000_ehf214223-bib-0002","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1056\/NEJMoa012175","article-title":"Long-term use of a left ventricular assist device for end-stage heart failure","volume":"345","author":"Rose","year":"2001","journal-title":"N Engl J Med"},{"key":"2026012114124493000_ehf214223-bib-0003","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.jacc.2015.07.075","article-title":"Risk assessment and comparative effectiveness of left ventricular assist device and medical management in ambulatory heart failure patients: results from the ROADMAP study","volume":"66","author":"Estep","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2026012114124493000_ehf214223-bib-0004","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1056\/NEJMoa1610426","article-title":"A fully magnetically levitated circulatory pump for advanced heart failure","volume":"376","author":"Mehra","year":"2017","journal-title":"N Engl J Med"},{"key":"2026012114124493000_ehf214223-bib-0005","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1056\/NEJMoa1602954","article-title":"Intrapericardial left ventricular assist device for advanced heart failure","volume":"376","author":"Rogers","year":"2017","journal-title":"N Engl J Med"},{"key":"2026012114124493000_ehf214223-bib-0006","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.cardfail.2015.04.013","article-title":"Advanced (stage D) heart failure: a statement from the Heart Failure Society of America Guidelines Committee","volume":"21","author":"Fang","year":"2015","journal-title":"J Card Fail"},{"key":"2026012114124493000_ehf214223-bib-0007","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"2026012114124493000_ehf214223-bib-0008","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1161\/CIRCULATIONAHA.120.048739","article-title":"Renal and cardiovascular effects of SGLT2 inhibition in combination with loop diuretics in patients with type 2 diabetes and chronic heart failure: the RECEDE-CHF trial","volume":"142","author":"Mordi","year":"2020","journal-title":"Circulation"},{"key":"2026012114124493000_ehf214223-bib-0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"28","author":"Lang","year":"2015","journal-title":"J Am Soc Echocardiogr"},{"key":"2026012114124493000_ehf214223-bib-0010","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1093\/ehjci\/jew082","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"17","author":"Nagueh","year":"2016","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026012114124493000_ehf214223-bib-0011","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1016\/j.jacc.2017.02.018","article-title":"Left ventricular assist device as a bridge to recovery for patients with advanced heart failure","volume":"69","author":"Jakovljevic","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026012114124493000_ehf214223-bib-0012","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1001\/jama.294.10.1240","article-title":"Risk-treatment mismatch in the pharmacotherapy of heart failure","volume":"294","author":"Lee","year":"2005","journal-title":"JAMA"},{"key":"2026012114124493000_ehf214223-bib-0013","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026012114124493000_ehf214223-bib-0014","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1161\/CIRCHEARTFAILURE.113.000761","article-title":"Hospital variation in intravenous inotrope use for patients hospitalized with heart failure: insights from Get With The Guidelines","volume":"7","author":"Allen","year":"2014","journal-title":"Circ Heart Fail"},{"key":"2026012114124493000_ehf214223-bib-0015","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1056\/NEJM199111213252103","article-title":"Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group","volume":"325","author":"Packer","year":"1991","journal-title":"N Engl J Med"},{"key":"2026012114124493000_ehf214223-bib-0016","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1056\/NEJM199812173392503","article-title":"A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone Trial Investigators","volume":"339","author":"Cohn","year":"1998","journal-title":"N Engl J Med"},{"key":"2026012114124493000_ehf214223-bib-0017","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1093\/eurheartj\/ehp338","article-title":"Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials","volume":"30","author":"Metra","year":"2009","journal-title":"Eur Heart J"},{"key":"2026012114124493000_ehf214223-bib-0018","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0735-1097(87)80223-1","article-title":"Efficacy and safety of sustained (48 hour) intravenous infusions of milrinone in patients with severe congestive heart failure: a multicenter study","volume":"9","author":"Anderson","year":"1987","journal-title":"J Am Coll Cardiol"},{"key":"2026012114124493000_ehf214223-bib-0019","first-page":"109","article-title":"Intravenous milrinone in treatment of advanced congestive heart failure","volume":"30","author":"Zewail","year":"2003","journal-title":"Tex Heart Inst J"},{"key":"2026012114124493000_ehf214223-bib-0020","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0002-8703(99)70107-9","article-title":"Intermittent milrinone effect on long-term hemodynamic profile in patients with severe congestive heart failure","volume":"138","author":"Hatzizacharias","year":"1999","journal-title":"Am Heart J"},{"key":"2026012114124493000_ehf214223-bib-0021","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0002-8703(98)70352-7","article-title":"Beneficial effects of intermittent home administration of the inotrope\/vasodilator milrinone in patients with end-stage congestive heart failure: a preliminary study","volume":"135","author":"Cesario","year":"1998","journal-title":"Am Heart J"},{"key":"2026012114124493000_ehf214223-bib-0022","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/clc.23802","article-title":"Repetitive milrinone therapy in ambulatory advanced heart failure patients","volume":"45","author":"Laufer-Perl","year":"2022","journal-title":"Clin Cardiol"},{"key":"2026012114124493000_ehf214223-bib-0023","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1002\/ehf2.13807","article-title":"Intermittent inotropic therapy with levosimendan vs. milrinone in advanced heart failure patients","volume":"9","author":"Milwidsky","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026012114124493000_ehf214223-bib-0024","first-page":"227","article-title":"Levosimendan: current data, clinical use and future development","volume":"5","author":"Nieminen","year":"2013","journal-title":"Heart Lung Vessel"},{"key":"2026012114124493000_ehf214223-bib-0025","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002444","article-title":"Clinical effectiveness of hydralazine-isosorbide dinitrate therapy in patients with heart failure and reduced ejection fraction: findings from the Get With The Guidelines-Heart Failure registry","volume":"9","author":"Khazanie","year":"2016","journal-title":"Circ Heart Fail"},{"key":"2026012114124493000_ehf214223-bib-0026","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1056\/NEJM199108013250502","article-title":"A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure","volume":"325","author":"Cohn","year":"1991","journal-title":"N Engl J Med"},{"key":"2026012114124493000_ehf214223-bib-0027","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jacc.2019.05.064","article-title":"Digoxin discontinuation and outcomes in patients with heart failure with reduced ejection fraction","volume":"74","author":"Malik","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026012114124493000_ehf214223-bib-0028","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/clc.22889","article-title":"Digoxin use and lower risk of 30-day all-cause readmission in older patients with heart failure and reduced ejection fraction receiving beta-blockers","volume":"41","author":"Lam","year":"2018","journal-title":"Clin Cardiol"},{"key":"2026012114124493000_ehf214223-bib-0029","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.jacc.2005.08.060","article-title":"The prevalence of thiamin deficiency in hospitalized patients with congestive heart failure","volume":"47","author":"Hanninen","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2026012114124493000_ehf214223-bib-0030","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00392-011-0376-2","article-title":"Thiamine supplementation in symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled, cross-over pilot study","volume":"101","author":"Schoenenberger","year":"2012","journal-title":"Clin Res Cardiol"},{"key":"2026012114124493000_ehf214223-bib-0031","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0002-9343(99)80349-0","article-title":"Improved left ventricular function after thiamine supplementation in patients with congestive heart failure receiving long-term furosemide therapy","volume":"98","author":"Shimon","year":"1995","journal-title":"Am J Med"},{"key":"2026012114124493000_ehf214223-bib-0032","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1016\/j.jacc.2016.03.508","article-title":"Effects of vitamin D on cardiac function in patients with chronic HF: the VINDICATE study","volume":"67","author":"Witte","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2026012114124493000_ehf214223-bib-0033","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.jchf.2014.06.008","article-title":"The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial","volume":"2","author":"Mortensen","year":"2014","journal-title":"JACC Heart Fail"},{"key":"2026012114124493000_ehf214223-bib-0034","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"2026012114124493000_ehf214223-bib-0035","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"key":"2026012114124493000_ehf214223-bib-0036","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N Engl J Med"},{"key":"2026012114124493000_ehf214223-bib-0037","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N Engl J Med"},{"key":"2026012114124493000_ehf214223-bib-0038","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/ejhf.1713","article-title":"Randomized, double-blind, placebo-controlled, multicentre pilot study on the effects of empagliflozin on clinical outcomes in patients with acute decompensated heart failure (EMPA-RESPONSE-AHF)","volume":"22","author":"Damman","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2026012114124493000_ehf214223-bib-0039","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1002\/ejhf.765","article-title":"Comparative effectiveness of transitional care services in patients discharged from the hospital with heart failure: a systematic review and network meta-analysis","volume":"19","author":"Van Spall","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2026012114124493000_ehf214223-bib-0040","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1161\/CIRCULATIONAHA.120.046415","article-title":"Prospective multicenter study of myocardial recovery using left ventricular assist devices (RESTAGE-HF [Remission from Stage D Heart Failure]): medium-term and primary end point results","volume":"142","author":"Birks","year":"2020","journal-title":"Circulation"},{"key":"2026012114124493000_ehf214223-bib-0041","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.jacc.2016.07.743","article-title":"Cardiac recovery during long-term left ventricular assist device support","volume":"68","author":"Wever-Pinzon","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2026012114124493000_ehf214223-bib-0042","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1161\/CIRCULATIONAHA.116.024470","article-title":"Sheet-like remodeling of the transverse tubular system in human heart failure impairs excitation-contraction coupling and functional recovery by mechanical unloading","volume":"135","author":"Seidel","year":"2017","journal-title":"Circulation"},{"key":"2026012114124493000_ehf214223-bib-0043","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1016\/j.jacc.2019.02.049","article-title":"Myofibroblast phenotype and reversibility of fibrosis in patients with end-stage heart failure","volume":"73","author":"Nagaraju","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026012114124493000_ehf214223-bib-0044","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1161\/CIRCULATIONAHA.109.933960","article-title":"Reversal of severe heart failure with a continuous-flow left ventricular assist device and pharmacological therapy: a prospective study","volume":"123","author":"Birks","year":"2011","journal-title":"Circulation"},{"key":"2026012114124493000_ehf214223-bib-0045","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.healun.2012.11.019","article-title":"Combining neurohormonal blockade with continuous-flow left ventricular assist device support for myocardial recovery: a single-arm prospective study","volume":"32","author":"Patel","year":"2013","journal-title":"J Heart Lung Transplant"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ehf2.14223","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ehf2.14223","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/10\/1\/601\/65108292\/eschf_10_1_601.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/10\/1\/601\/65108292\/eschf_10_1_601.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T19:14:25Z","timestamp":1769022865000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/10\/1\/601\/8304994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,15]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,11,15]]},"published-print":{"date-parts":[[2023,2,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.14223","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,2]]},"published":{"date-parts":[[2022,11,15]]},"assertion":[{"value":"2022-04-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}